 |
 |

Midtrimester AbortionIntra-amniotic Instillation of Hyperosmolar Urea and Prostaglandin F2 v Dilatation and Evacuation
Michael E. Kafrissen, MD, MSPH;
Kenneth F. Schulz, MBA;
David A. Grimes, MD;
Willard Cates, Jr, MD, MPH
JAMA. 1984;251(7):916-919.
Abstract
 |  |
Although dilatation and evacuation (D&E) is currently the most common method of midtrimester abortion in the United States, the intra-amniotic instillation of hyperosmolar urea and prostaglandin F2 combined (U-P) has been proposed as a safer technique. To evaluate the comparative safety of U-P and D&E, we analyzed 2,805 U-P and 9,572 D&E abortions at 13 to 24 menstrual weeks' gestation. The U-P procedure resulted in significantly more serious complications than D&E (1.03 v 0.49 per 100 abortions). After adjusting for patient age, race, parity, follow-up information, and preexisting conditions, the relative risk of serious complications associated with U-P was 1.9 (95% confidence interval, 1.2 to 3.1). This advantage for D&E stems from its applicability to the 13- to 16-week interval. Although D&E appears to be safer overall in the midtrimester, for women obtaining abortion after 16 weeks, the rates of serious complications were comparable, with a relative risk of 1.0 (95% confidence interval, 0.4 to 2.5).
(JAMA 1984;251:916-919)
Author Affiliations
From the Division of Reproductive Health, Center for Health Promotion and Education, Centers for Disease Control, Atlanta.
Footnotes
Reprints not available.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Abortion, Health, and the Law
Greene and Ecker
NEJM 2004;350:184-186.
FULL TEXT
|